Cargando…

Transposon-triggered innate immune response confers cancer resistance to the blind mole rat

Blind mole rats (BMRs) are small rodents, characterized by exceptionally long lifespan (> 21 years) and resistance to both spontaneous and induced tumorigenesis. Here we report that cancer resistance in the BMR is mediated by retrotransposable elements (RTEs). BMR cells and tissues express very l...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yang, Oreskovic, Ena, Zhang, Quanwei, Lu, Quan, Gilman, Abbey, Lin, Yifei S., He, Junyue, Zheng, Zhizhong, Lu, J. Yuyang, Lee, Jina, Ke, Zhonghe, Ablaeva, Julia, Sweet, Matthew, Horvath, Steve, Zhang, Zhengdong, Nevo, Eviatar, Seluanov, Andrei, Gorbunova, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488014/
https://www.ncbi.nlm.nih.gov/pubmed/34556881
http://dx.doi.org/10.1038/s41590-021-01027-8
_version_ 1784578061672382464
author Zhao, Yang
Oreskovic, Ena
Zhang, Quanwei
Lu, Quan
Gilman, Abbey
Lin, Yifei S.
He, Junyue
Zheng, Zhizhong
Lu, J. Yuyang
Lee, Jina
Ke, Zhonghe
Ablaeva, Julia
Sweet, Matthew
Horvath, Steve
Zhang, Zhengdong
Nevo, Eviatar
Seluanov, Andrei
Gorbunova, Vera
author_facet Zhao, Yang
Oreskovic, Ena
Zhang, Quanwei
Lu, Quan
Gilman, Abbey
Lin, Yifei S.
He, Junyue
Zheng, Zhizhong
Lu, J. Yuyang
Lee, Jina
Ke, Zhonghe
Ablaeva, Julia
Sweet, Matthew
Horvath, Steve
Zhang, Zhengdong
Nevo, Eviatar
Seluanov, Andrei
Gorbunova, Vera
author_sort Zhao, Yang
collection PubMed
description Blind mole rats (BMRs) are small rodents, characterized by exceptionally long lifespan (> 21 years) and resistance to both spontaneous and induced tumorigenesis. Here we report that cancer resistance in the BMR is mediated by retrotransposable elements (RTEs). BMR cells and tissues express very low levels of DNA methyltransferase 1 (DNMT1). Upon cell hyperplasia, the BMR genome DNA loses methylation, resulting in activation of RTEs. Up-regulated RTEs form cytoplasmic RNA/DNA hybrids, which activate cGAS-STING pathway to induce cell death. Although this mechanism is enhanced in the BMR, we show that it functions in mice and human. We propose that RTEs were coopted to serve as tumor suppressors that monitor cell proliferation and are activated in premalignant cells to trigger cell death via activation of innate immune response. RTEs activation is a double-edged sword, serving as a tumor suppressor but in late life contributing to aging via induction of sterile inflammation.
format Online
Article
Text
id pubmed-8488014
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-84880142022-03-23 Transposon-triggered innate immune response confers cancer resistance to the blind mole rat Zhao, Yang Oreskovic, Ena Zhang, Quanwei Lu, Quan Gilman, Abbey Lin, Yifei S. He, Junyue Zheng, Zhizhong Lu, J. Yuyang Lee, Jina Ke, Zhonghe Ablaeva, Julia Sweet, Matthew Horvath, Steve Zhang, Zhengdong Nevo, Eviatar Seluanov, Andrei Gorbunova, Vera Nat Immunol Article Blind mole rats (BMRs) are small rodents, characterized by exceptionally long lifespan (> 21 years) and resistance to both spontaneous and induced tumorigenesis. Here we report that cancer resistance in the BMR is mediated by retrotransposable elements (RTEs). BMR cells and tissues express very low levels of DNA methyltransferase 1 (DNMT1). Upon cell hyperplasia, the BMR genome DNA loses methylation, resulting in activation of RTEs. Up-regulated RTEs form cytoplasmic RNA/DNA hybrids, which activate cGAS-STING pathway to induce cell death. Although this mechanism is enhanced in the BMR, we show that it functions in mice and human. We propose that RTEs were coopted to serve as tumor suppressors that monitor cell proliferation and are activated in premalignant cells to trigger cell death via activation of innate immune response. RTEs activation is a double-edged sword, serving as a tumor suppressor but in late life contributing to aging via induction of sterile inflammation. 2021-09-23 2021-10 /pmc/articles/PMC8488014/ /pubmed/34556881 http://dx.doi.org/10.1038/s41590-021-01027-8 Text en https://www.springernature.com/gp/open-research/policies/accepted-manuscript-termsUsers may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms
spellingShingle Article
Zhao, Yang
Oreskovic, Ena
Zhang, Quanwei
Lu, Quan
Gilman, Abbey
Lin, Yifei S.
He, Junyue
Zheng, Zhizhong
Lu, J. Yuyang
Lee, Jina
Ke, Zhonghe
Ablaeva, Julia
Sweet, Matthew
Horvath, Steve
Zhang, Zhengdong
Nevo, Eviatar
Seluanov, Andrei
Gorbunova, Vera
Transposon-triggered innate immune response confers cancer resistance to the blind mole rat
title Transposon-triggered innate immune response confers cancer resistance to the blind mole rat
title_full Transposon-triggered innate immune response confers cancer resistance to the blind mole rat
title_fullStr Transposon-triggered innate immune response confers cancer resistance to the blind mole rat
title_full_unstemmed Transposon-triggered innate immune response confers cancer resistance to the blind mole rat
title_short Transposon-triggered innate immune response confers cancer resistance to the blind mole rat
title_sort transposon-triggered innate immune response confers cancer resistance to the blind mole rat
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488014/
https://www.ncbi.nlm.nih.gov/pubmed/34556881
http://dx.doi.org/10.1038/s41590-021-01027-8
work_keys_str_mv AT zhaoyang transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT oreskovicena transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT zhangquanwei transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT luquan transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT gilmanabbey transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT linyifeis transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT hejunyue transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT zhengzhizhong transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT lujyuyang transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT leejina transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT kezhonghe transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT ablaevajulia transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT sweetmatthew transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT horvathsteve transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT zhangzhengdong transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT nevoeviatar transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT seluanovandrei transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat
AT gorbunovavera transposontriggeredinnateimmuneresponseconferscancerresistancetotheblindmolerat